Home » Topics » Conferences

Conferences
RSS

Phase II results with T-cell receptor peptides in RA promising

Nov. 20, 1997

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

Novartis' NK1 antagonist in clinical studies for pain

Nov. 20, 1997

GL-701 shows significant steroid-sparing effects in women with active SLE

Nov. 20, 1997

New ACAT inhibitor from Pierre Fabre

Nov. 20, 1997

Enbrel phase III and long-term safety data presented at rheumatology meeting

Nov. 20, 1997

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Nov. 20, 1997

Effects of rPAF-AH in opossums with severe pancreatitis

Nov. 20, 1997

Thalidomide proves effective in HIV-associated proctitis

Nov. 20, 1997

L-Arginine safe and effective in spastic esophageal motor disorders

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026